Macquarie Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,791,235
Closed -$16M 1705
2025
Q1
$16M Buy
4,791,235
+40,301
+0.8% +$208K 0.02% 718
2024
Q4
$35.2M Buy
4,750,934
+1,560,898
+49% +$14.5M 0.04% 505
2024
Q3
$30M Buy
+3,190,036
New +$30.2M 0.03% 584
2024
Q2
Sell
-122,053
Closed -$1.81M 2009
2024
Q1
$1.81M Buy
+122,053
New +$1.42M ﹤0.01% 1248
2023
Q2
Sell
-55,835
Closed -$341K 1690
2023
Q1
$341K Sell
55,835
-674
-1% -$4.65K ﹤0.01% 1506
2022
Q4
$361K Sell
56,509
-7,347
-12% -$57.4K ﹤0.01% 1551
2022
Q3
$634K Sell
63,856
-2,537
-4% -$29.3K ﹤0.01% 1493
2022
Q2
$733K Buy
66,393
+1,721
+3% +$22.6K ﹤0.01% 1542
2022
Q1
$1.08K Buy
64,672
+7,019
+12% +$109K ﹤0.01% 1535
2021
Q4
$1.1M Buy
57,653
+9,472
+20% +$209K ﹤0.01% 1537
2021
Q3
$1.19M Sell
48,181
-1,700
-3% -$40.1K ﹤0.01% 1545
2021
Q2
$1.3M Buy
49,881
+6,343
+15% +$165K ﹤0.01% 1543
2021
Q1
$1.38M Buy
43,538
+4,609
+12% +$191K ﹤0.01% 1312
2020
Q4
$1.81M Sell
38,929
-12,046
-24% -$478K ﹤0.01% 1135
2020
Q3
$1.68M Sell
50,975
-1,189
-2% -$36.5K ﹤0.01% 1090
2020
Q2
$1.43M Buy
52,164
+6,809
+15% +$224K ﹤0.01% 1112
2020
Q1
$1.36M Sell
45,355
-16,137
-26% -$428K ﹤0.01% 1015
2019
Q4
$1.7M Sell
61,492
-2,132
-3% -$48.5K ﹤0.01% 1084
2019
Q3
$1.16M Buy
63,624
+34
+0.1% +$752 ﹤0.01% 1176
2019
Q2
$1.56M Sell
63,590
-13,620
-18% -$205K ﹤0.01% 1084
2019
Q1
$734K Buy
+77,210
New +$750K ﹤0.01% 1253

Other funds holding IOVA